Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.245
Neutral
RSI(14)
41.720
Neutral
STOCH(KDJ)(9,3,3)
28.007
Sell
ATR(14)
2.085
Low Volatility
CCI(14)
-69.837
Neutral
Williams %R
65.379
Sell
TRIX(12,20)
-0.002
Sell
StochRSI(14)
0.000
Oversold
LeMaitre Vascular Inc
LMAT86.610USD
-1.940-2.19%
Close 10/31, 16:00（ET）Quotes delayed by 15 min
1.96BMarket Cap
41.61P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of LeMaitre Vascular Inc
Currency: USD Updated: 2025-10-31Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
LeMaitre Vascular Inc's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
10
analysts
Buy
Current Rating
104.625
Target Price
+18.15%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
LeMaitre Vascular Inc Highlights
StrengthsRisks
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.01% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 219.86M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.
Undervalued
The company’s latest PE is 41.44, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 21.62M shares, decreasing 3.56% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 6.51K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.42.
Financial Health
Currency: USD Updated: 2025-10-31The company's current financial score is 9.24, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 64.23M, representing a year-over-year increase of 15.01%, while its net profit experienced a year-over-year increase of 16.51%.
Score
Financials
7.52
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
9.05
Operational Efficiency
10.00
Growth Potential
10.00
Shareholder Returns
9.62
LeMaitre Vascular Inc's Company Valuation
Currency: USD Updated: 2025-10-31The company’s current valuation score is 4.49, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 41.44, which is 75.66% below the recent high of 72.80 and 11.03% above the recent low of 36.87.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 34/210
No Data
Earnings Forecast
Currency: USD Updated: 2025-10-31The company’s current earnings forecast score is 7.60, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for LeMaitre Vascular Inc is 103.50, with a high of 120.00 and a low of 92.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
10
analysts
Buy
Current Rating
104.625
Target Price
+18.15%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
89
Total
4
Median
7
Average
Company name
Ratings
Analysts
LeMaitre Vascular Inc
LMAT
10
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-10-31The company’s current price momentum score is 7.04, which is higher than the Healthcare Equipment & Supplies industry's average of 6.65. Sideways: Currently, the stock price is trading between the resistance level at 90.46 and the support level at 83.47, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
88.738
Sell
MA10
88.977
Sell
MA20
87.942
Sell
MA50
90.603
Sell
MA100
88.086
Sell
MA200
88.268
Sell
Institutional Confidence
Currency: USD Updated: 2025-10-31The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 95.49%, representing a quarter-over-quarter decrease of 7.53%. The largest institutional shareholder is The Vanguard, holding a total of 1.60M shares, representing 7.06% of shares outstanding, with 0.70% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
LeMaitre (George W)
Conestoga Capital Advisors, LLC
Copeland Capital Management, LLC
Geneva Capital Management LLC
State Street Investment Management (US)
Congress Asset Management Company, LLP
First Trust Advisors L.P.
Geode Capital Management, L.L.C.
1
2
Risk Assessment
Currency: USD Updated: 2025-10-31The company’s current risk assessment score is 7.14, which is higher than the Healthcare Equipment & Supplies industry's average of 4.56. The company's beta value is 0.77. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.77
VaR
+3.11%
240-Day Maximum Drawdown
+27.86%
240-Day Volatility
+40.83%
Return
Best Daily Return
60 days
+4.02%
120 days
+8.91%
5 years
+15.23%
Worst Daily Return
60 days
-3.58%
120 days
-3.83%
5 years
-19.09%
Sharpe Ratio
60 days
-1.15
120 days
+0.72
5 years
+0.59
Risk Assessment
Maximum Drawdown
240 days
+27.86%
3 years
+33.48%
5 years
+38.34%
Return-to-Drawdown Ratio
240 days
-0.53
3 years
+0.90
5 years
+0.47
Skewness
240 days
-0.91
3 years
+0.22
5 years
-0.44
Volatility
Realised Volatility
240 days
+40.83%
5 years
+39.32%
Standardised True Range
240 days
+3.31%
5 years
+2.36%
Downside Risk-Adjusted Return
120 days
+128.32%
240 days
+128.32%
Maximum Daily Upside Volatility
60 days
+16.95%
Maximum Daily Downside Volatility
60 days
+23.89%
Liquidity
Average Turnover Rate
60 days
+0.71%
120 days
+0.83%
5 years
--
Turnover Deviation
20 days
+41.74%
60 days
+4.63%
120 days
+22.49%
Peer Comparison
Healthcare Equipment & Supplies
LeMaitre Vascular Inc
LMAT
7.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Boston Scientific Corp
BSX
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
CSTL
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hologic Inc
HOLX
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
